Related references
Note: Only part of the references are listed.Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models
Bruna Costa et al.
CELLS (2020)
'Omics Approaches to Explore the Breast Cancer Landscape
Joseph Parsons et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis
Yvonne A. Evrard et al.
CANCER RESEARCH (2020)
Innovations, challenges, and minimal information for standardization of humanized mice
Renata Stripecke et al.
EMBO MOLECULAR MEDICINE (2020)
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Amilcar Flores-Morales et al.
CLINICAL CANCER RESEARCH (2019)
Genomic evolution of cancer models: perils and opportunities
Uri Ben-David et al.
NATURE REVIEWS CANCER (2019)
Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases
Arnaud Blomme et al.
ONCOGENE (2018)
Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
Feifei Zhang et al.
CANCER COMMUNICATIONS (2018)
Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients
Ming Zhan et al.
CANCER COMMUNICATIONS (2018)
TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication
Daniel W. H. Ho et al.
GUT (2017)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
Kuan-lin Huang et al.
NATURE COMMUNICATIONS (2017)
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery
Alan H. Bryce et al.
ONCOTARGET (2017)
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Terrence F. Meehan et al.
CANCER RESEARCH (2017)
Patient-Derived Xenograft: An Adjuvant Technology for the Treatment of Metastatic Disease
Guilhem Bousquet et al.
PATHOBIOLOGY (2016)
Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
Keisuke Yamamoto et al.
ONCOTARGET (2016)
Examining the utility of patient-derived xenograft mouse models
Samuel Aparicio et al.
NATURE REVIEWS CANCER (2015)
Patient-Derived Xenografts for Individualized Care in Advanced Sarcoma
Justin Stebbing et al.
CANCER (2014)
A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
Manuel Hidalgo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Share Paper
